Vera Kemp

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 7

Top Topics

Tyrosine Kinase

Cerebrospinal Fluid

Top Venues

International journal of molecular sciences

Cancer gene therapy

This page only lists publications with an associated author ORCID identifier.

Publications

Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink, Wytske M van Weerden
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines. International journal of molecular sciences 24 (3) (2023)
Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink, Wytske M van Weerden
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines. International journal of molecular sciences 24 (3) (2023)
Diana J M van den Wollenberg, Vera Kemp, Martijn J W E Rabelink, Wytske M van Weerden
Reovirus Type 3 Dearing Variants Do Not Induce Necroptosis in RIPK3-Expressing Human Tumor Cell Lines. International journal of molecular sciences 24 (3) (2023)
Tom J Harryvan, Matteo Golo, Nicole Dam, Mark J A Schoonderwoerd, Elham Aida Farshadi, Marten Hornsveld, Wytske M van Weerden, Lukas J A C Hawinkels, Vera Kemp
Gastrointestinal cancer-associated fibroblasts expressing Junctional Adhesion Molecule-A are amenable to infection by oncolytic reovirus. Cancer gene therapy (2022)
Selas T F Bots, Vera Kemp, Iris J C Dautzenberg, Wytske M van Weerden
Genome Analyses of Ten New Ape Adenoviruses with Similarity to Human Mastadenovirus C. International journal of molecular sciences 23 (17) (2022)
Anne Everts, Melissa Bergeman, Grant McFadden, Vera Kemp
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses. Biomedicines 8 (11) (2020)
Vera Kemp, Diana J M van den Wollenberg, Marcel G M Camps, Thorbald van Hall, Priscilla Kinderman, Nadine Pronk-van Montfoort, Wytske M van Weerden
Arming oncolytic reovirus with GM-CSF gene to enhance immunity. Cancer gene therapy 26 (9-10) (2018)